CJC-1295 (No DAC) + Ipamorelin (5mg/5mg)

Description

CJC-1295 (No DAC) + Ipamorelin (5mg/5mg) — GHRH Analogue + Selective Ghrelin-Receptor Agonist Blend

This product combines CJC-1295 (No DAC), a GHRH(1-29) analogue, with Ipamorelin, a selective ghrelin receptor (GHS-R1a) agonist pentapeptide, co-lyophilised in a single vial. It is supplied for in vitro laboratory research only.

Research context

Preclinical literature has examined combined GHRH-receptor and GHS-R1a agonism in pituitary cell and tissue culture models, using receptor-binding and signalling assays to characterise concurrent pathway activation. Comparative studies have also examined receptor cross-talk and desensitisation patterns relative to either compound applied in isolation in vitro.

Specification

• Available sizes: 10mg
• Form: lyophilised powder
• Purity: ≥99% (HPLC)
• Testing: independently lot-tested by Horizon Analytical · Certificate of Analysis per lot

For laboratory research use only. This material is supplied to qualified researchers and institutions for in vitro investigational use. It is not a drug, food, cosmetic or medical device. It is not intended for human or veterinary use, for diagnosis, treatment, cure or prevention of any disease, or for any use outside a controlled laboratory environment. No statement on this site has been evaluated by the Food and Drug Administration. Keep out of reach of children.

Related Research

Compound family: CJC-1295 with DAC, CJC-1295 (No DAC), Ipamorelin, Sermorelin

Browse: Growth Factor & Endocrine Research · All Research Peptides

Reconstitution & Lab Testing: All products independently tested by Horizon Analytical. See our Reconstitution & Lab Testing FAQ. Reconstitution typically requires BAC Water.